Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis

Spremljeno u:
Bibliografski detalji
Izdano u:Am Health Drug Benefits
Glavni autori: Best, Jennie H., Abbass, Ibrahim, Tominna, Lenore, Reiss, William
Format: Artigo
Jezik:Inglês
Izdano: Engage Healthcare Communications, LLC 2020
Teme:
Letters to the Editor
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370831/
https://ncbi.nlm.nih.gov/pubmed/32724501
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items